Allied Healthcare Product EBIT

The latest EBIT for AHPI is $-4.6M as of June 2022. That compares with $1.9M in the prior-year period — down 343.7% year over year. That is below the Healthcare sector average of $22B. Investors often review this figure alongside Allied Healthcare Product's historical trend and sector peers before judging valuation or financial health.

Over the past year, AHPI's EBIT moved from $1.9M to $-4.6M — a 343.7% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Allied Healthcare Product's operating scale or balance-sheet position.

Against Healthcare companies, AHPI currently prints $-4.6M for EBIT, while the sector average sits near $22B. That is roughly 100.0% below the sector mean. Large gaps often invite a closer look at Allied Healthcare Product's growth, margins, and balance sheet.

A EBIT figure of $-4.6M for AHPI is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The Healthcare average is about $22B. Explore the charts below for those layers of context.

After noting AHPI's EBIT ($-4.6M), review year-over-year change from $1.9M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.